Study of SPY002-072 in healthy volunteers
This early-phase study will test a new investigational medicine called SPY002-072 in healthy volunteers. It helps researchers understand how the drug behaves in the body before testing it in patients with a specific condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are generally healthy with no major medical problems.
- You can stay at the study clinic for the entire confinement period and return for follow-up visits.
- You have not used recreational drugs (including marijuana) in the past 3 months.
- You do not currently smoke, vape, or use nicotine products.
- You have no history of severe allergic reactions.
- You have not donated blood in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called LY4088044 in healthy people to see how it affects the body. It helps doctors learn about the drug's safety before testing it in patients with a disease.
This trial tests a new drug called CAY001 in healthy volunteers to see how safe it is and how the body processes it. It may help researchers understand if the drug is safe enough to test in people with medical conditions later.
This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.
This is a Phase 1 study testing a new medicine called LY4178256. It will check how the drug is processed by the body and its safety in healthy volunteers. The results help doctors understand how to dose the drug in future studies.
This trial tests a new medicine called SPH9788 in healthy people to see how the body handles it. Volunteers must be generally healthy and follow lifestyle rules to help researchers understand the drug's safety and effects.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.